NN Investment Partners Holdings’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
OCBV
NN Investment Partners Holdings's RMD Position: Q1 2022 in Review
NN Investment Partners Holdings increased its ResMed (RMD) stake by 1.7% in Q1 2022, buying an estimated $122K and bringing the position to 30,399 shares worth $7.37M. The position accounts for 0.04% of the portfolio, ranked #336.
NN Investment Partners Holdings first reported a position in RMD in Q1 2016 and has held it in 25 quarters since. The position peaked at $28.8M in Q4 2018. 683 funds tracked by Wall St. Rank hold RMD as of Q1 2022.
- NN Investment Partners Holdings held 30,399 shares of ResMed worth $7.37M as of Q1 2022.
- NN Investment Partners Holdings bought 503 ResMed shares in Q1 2022, an estimated $122K.
- ResMed made up 0.04% of NN Investment Partners Holdings's portfolio in Q1 2022, its #336 holding.
- NN Investment Partners Holdings first reported a position in ResMed in Q1 2016 and has held it in 25 quarters since.
- NN Investment Partners Holdings's ResMed position peaked at $28.8M in Q4 2018.
- 683 funds tracked by Wall St. Rank held ResMed as of Q1 2022.
Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.